atopic dermatitis

AbbVie preps JAK atopic dermatitis candidate for phase 3
Fierce Biotech
Sun, 09/10/17 - 11:56 am
AbbVie
JAK inhibitors
clinical trials
atopic dermatitis
Upadacitinib
Sanofi
Regeneron
Dupixent
AbbVie adds more stellar data on ABT-494 — this time for atopic dermatitis
Endpoints
Thu, 09/7/17 - 09:46 am
AbbVie
ABT-494
atopic dermatitis
Upadacitinib
Is Another Blockbuster Drug on the Way for Regeneron Pharmaceuticals, Inc.?
Motley Fool
Mon, 10/10/16 - 09:03 am
Regeneron
Dupixent
Sanofi
atopic dermatitis
Galderma licenses PhII atopic dermatitis drug from Roche’s Chugai
Fierce Biotech
Fri, 07/22/16 - 11:47 am
Galderms
atopic dermatitis
Roche
Chugai
nemolizumab
Regeneron Pharmaceuticals Inc Jumps on Positive Clinical Data
Motley Fool
Sat, 04/2/16 - 02:00 pm
Regeneron
clinical trials
dupilumab
eczema
atopic dermatitis
Anacor Shares Surge To All-Time Highs After Phase 3 Trials Of Eczema Drug
Yahoo/Benzinga
Mon, 07/13/15 - 07:32 pm
Anacor
clinical trials
eczema
crisaborole
atopic dermatitis
Vanda's eczema drug fails mid-stage study, shares fall
Yahoo/Reuters
Thu, 03/5/15 - 08:12 am
Vanda Pharmaceuticals
eczema
atopic dermatitis
tradipitant
Sanofi-Regeneron drug tames eczema in study
Yahoo/Reuters
Wed, 07/9/14 - 05:09 pm
Sanofi
Regeneron
eczema
atopic dermatitis
dupilumab
Anacor Rises on Positive Data
Yahoo/Zacks.com
Thu, 11/14/13 - 05:52 pm
Anacor
atopic dermatitis
AN2728
Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at Upcoming Medical Meetings
PharmiWeb
Sat, 05/5/12 - 04:54 pm
Tavaborole
Anacor
AN2728
atopic dermatitis
Onychomycosis
antifungals

Pages